• Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald

    المصدر: Buzz FX / 01 فبراير 2025 06:11:10   America/New_York


    Aclaris Therapeutics (NASDAQ:ACRS) Rating Increased to Strong-Buy at Cantor Fitzgerald Written by MarketBeat February 1, 2025 Share Link copied to clipboard. Aclaris Therapeutics ( NASDAQ:ACRS - Get Free Report ) was upgraded by analysts at
    Read more...
شارك على،